- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02565017
Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System
23. juni 2020 opdateret af: Memorial Sloan Kettering Cancer Center
The purpose of this study is to learn what cancer patients think about IBM Watson Oncology.
IBM Watson Oncology is a computer program designed to help inform oncologists about the best chemotherapy choices for their patients.
The investigators will conduct focus groups with cancer patients who have received chemotherapy treatment at MSK in order to understand cancer patients' thoughts about IBM Watson Oncology.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
70
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
New York
-
New York, New York, Forenede Stater, 10065
- Memorial Sloan Kettering Cancer Center
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
MSKCC clinics
Beskrivelse
Inclusion Criteria:
- MSKCC patient 18 years or older
Breast, lung, or colorectal cancer MSK patient as per EMR or clinician judgment having either:
- Chemotherapeutic adjuvant or neoadjuvant treatment with the first chemo visit occurring within the past 8 months and primary treatment (i.e., surgery), occurring within the past 6 months)at MSK
- OR chemotherapeutic treatment for metastatic disease with the first chemo visit occurring within the past 8 months at MSK
- OR chemotherapeutic treatment through an on-going MSK clinical trial as per clinician
- Residing in New York metro-area
Exclusion Criteria:
- Non-English speakers because we do not have the resources to conduct and translate the focus groups into other languages
- Patients who are not or will not receive their cancer care at MSKCC.
- Patient unwilling or unable to provide informed consent
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kohorte
- Tidsperspektiver: Fremadrettet
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
---|---|
Breast Cancer
and treatment type (chemotherapeutic adjuvant (i.e., chemotherapy delivered after primary therapy/surgery) or neoadjuvant (i.e., chemotherapy delivered prior to primary therapy/surgery) treatment, chemotherapeutic treatment for metastatic disease, or chemotherapeutic treatment through a clinical trial).
|
After the presentation of the of IBM Watson Oncology at the opening of the focus group, participants will be asked to fill out a de-identified brief 15-item questionnaire to assess participants' first impressions of IBM Watson Oncology.
The questionnaire will be self administered, and will take approximately 5 minutes to complete.
Completed questionnaires will be collected by a member of the study staff, and the focus group will proceed with introductions.
The focus group will be audio recorded from the completion of the introductions and notes will be taken.
The focus group guide will address the study aims.
At the end of the focus group, participants will complete a 7-item questionnaire to capture simple demographic information including education, income, and health literacy.
This questionnaire will take 3-5 minutes to complete.
|
Lung Cancer
and treatment type (chemotherapeutic adjuvant (i.e., chemotherapy delivered after primary therapy/surgery) or neoadjuvant (i.e., chemotherapy delivered prior to primary therapy/surgery) treatment, chemotherapeutic treatment for metastatic disease, or chemotherapeutic treatment through a clinical trial).
|
After the presentation of the of IBM Watson Oncology at the opening of the focus group, participants will be asked to fill out a de-identified brief 15-item questionnaire to assess participants' first impressions of IBM Watson Oncology.
The questionnaire will be self administered, and will take approximately 5 minutes to complete.
Completed questionnaires will be collected by a member of the study staff, and the focus group will proceed with introductions.
The focus group will be audio recorded from the completion of the introductions and notes will be taken.
The focus group guide will address the study aims.
At the end of the focus group, participants will complete a 7-item questionnaire to capture simple demographic information including education, income, and health literacy.
This questionnaire will take 3-5 minutes to complete.
|
Colorectal Cancer
and treatment type (chemotherapeutic adjuvant (i.e., chemotherapy delivered after primary therapy/surgery) or neoadjuvant (i.e., chemotherapy delivered prior to primary therapy/surgery) treatment, chemotherapeutic treatment for metastatic disease, or chemotherapeutic treatment through a clinical trial).
|
After the presentation of the of IBM Watson Oncology at the opening of the focus group, participants will be asked to fill out a de-identified brief 15-item questionnaire to assess participants' first impressions of IBM Watson Oncology.
The questionnaire will be self administered, and will take approximately 5 minutes to complete.
Completed questionnaires will be collected by a member of the study staff, and the focus group will proceed with introductions.
The focus group will be audio recorded from the completion of the introductions and notes will be taken.
The focus group guide will address the study aims.
At the end of the focus group, participants will complete a 7-item questionnaire to capture simple demographic information including education, income, and health literacy.
This questionnaire will take 3-5 minutes to complete.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Acceptability of IBM Watson Oncology
Tidsramme: 1 year
|
Data collected through the brief questionnaires (e.g.,initial impressions of IBM Watson Oncology, sociodemographics) will be entered into an SPSS data file on the secure MSK server.
|
1 year
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Hjælpsomme links
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
15. september 2015
Primær færdiggørelse (Faktiske)
22. juni 2020
Studieafslutning (Faktiske)
22. juni 2020
Datoer for studieregistrering
Først indsendt
30. september 2015
Først indsendt, der opfyldte QC-kriterier
30. september 2015
Først opslået (Skøn)
1. oktober 2015
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
25. juni 2020
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
23. juni 2020
Sidst verificeret
1. august 2019
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 15-226
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Brystkræft
-
Cairo UniversityIkke rekrutterer endnu
-
Abouqir General HospitalAlexandria UniversityRekrutteringBreast Udseende Rekonstruktion DisproportionEgypten
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital og andre samarbejdspartnereAfsluttetDen kliniske anvendelsesvejledning af Conebeam Breast CTKina
-
ETOP IBCSG Partners FoundationAfsluttetBreast Cancer Invasive NosItalien
-
Spanish Breast Cancer Research GroupHoffmann-La Roche; Roche Farma, S.AAfsluttetBreast Cancer Invasive NosSpanien
-
Ontario Clinical Oncology Group (OCOG)Afsluttet
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology; Regional...UkendtBRCA1 mutation | Breast Cancer Invasive NosPolen
-
Aga Khan UniversityAfsluttetBrystkræft | Perforatorklap | Brysttumor | Oncoplasty | Breast-QPakistan
-
University Health Network, TorontoAfsluttetBreast Cancer Invasive Nos | Primær invasiv brystkræftCanada
-
KU LeuvenNovartisUkendtER Positive, HER2 Negative Breast Cancer NeoplasmaBelgien
Kliniske forsøg med Focus groups
-
Umeå UniversityIkke rekrutterer endnuHoftebrud | Anæstesi | Hæmodynamisk ustabilitet | Ekkokardiografi | Risikovurdering
-
Brown UniversityKeitner/Family Therapy Research GrantAfsluttetBrystkræft | Seksuel dysfunktion | ProstatakræftForenede Stater
-
Nantes University HospitalUkendt
-
University of California, Los AngelesAktiv, ikke rekrutterendeDepression | Stress, psykologisk | Stresslidelser, traumatiske | Angst | Forældre-barn relationer | Forældreskab | Følelsesmæssig stress | Håndteringsevne | Følelsesregulering | Traume, psykologisk | Opførsel, barnForenede Stater
-
University at BuffaloAfsluttetDyb venetrombose | LungeemboliForenede Stater
-
SAV-IOL SACEISOAfsluttet
-
University of CalgaryAfsluttetMundhule pladecellekarcinom, behandlet med kirurgiCanada
-
Butler HospitalNational Institute of Mental Health (NIMH); Brown UniversityTilmelding efter invitationSkizofreni | Maniodepressiv | Større depressionForenede Stater
-
Centro de Atenção ao Assoalho PélvicoIndústria Brasileira Equipamentos Médicos - IBRAMEDRekrutteringErektil dysfunktionBrasilien